CVRx, Inc. (CVRX)
0.55
+0.02
(+3.21%)
USD |
NASDAQ |
Nov 20, 11:18
CVRx Free Cash Flow : -42.04M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -42.04M |
| June 30, 2026 | -41.05M |
| March 31, 2026 | -40.16M |
| December 31, 2025 | -40.75M |
| September 30, 2025 | -38.98M |
| June 30, 2025 | -39.43M |
| March 31, 2025 | -41.57M |
| December 31, 2024 | -40.50M |
| September 30, 2024 | -40.45M |
| June 30, 2024 | -38.17M |
| March 31, 2024 | -40.94M |
| December 31, 2023 | -39.61M |
| Date | Value |
|---|---|
| September 30, 2023 | -42.52M |
| June 30, 2023 | -45.72M |
| March 31, 2023 | -42.91M |
| December 31, 2022 | -43.36M |
| September 30, 2022 | -40.00M |
| June 30, 2022 | -38.02M |
| March 31, 2022 | -34.71M |
| December 31, 2021 | -28.92M |
| September 30, 2021 | -25.55M |
| June 30, 2021 | -21.44M |
| March 31, 2021 | -16.95M |
| December 31, 2020 | -16.41M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Stereotaxis, Inc. | -15.50M |
| Accuray, Inc. | -37.28M |
| Orthofix Medical, Inc. | -43.11M |
| ResMed, Inc. | 1.588B |
| Rockwell Medical, Inc. | 0.828M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.90M |
| Cash from Investing (Quarterly) | -0.098M |
| Cash from Financing (Quarterly) | 5.155M |
| Free Cash Flow Per Share (Quarterly) | -0.4035 |
| Free Cash Flow to Equity (Quarterly) | -10.99M |
| Free Cash Flow to Firm (Quarterly) | -9.388M |
| Free Cash Flow Yield | -268.4% |